NCT05266898 2025-04-18
AGO-Gard
Louisiana State University Health Sciences Center in New Orleans
Phase 4 Recruiting
Clinical Trials
10 trialsNCT03629886 2024-03-15
Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study
GlaxoSmithKline
Phase 4 Completed
NCT05426148 2022-06-29
Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female
Xiamen Innovax Biotech Co., Ltd
Phase 4 Completed
NCT03105856 2020-08-10
FASTER
Instituto Nacional de Salud Publica, Mexico
Phase 4 Completed
NCT01544478 2018-11-28
V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110)
Merck Sharp & Dohme LLC
Phase 4 Completed
NCT02629510 2017-05-31
TACO
Asan Medical Center
Phase 4 Unknown
NCT02368054 2016-08-19
HSBAPCB
Helse Fonna
Phase 4 Completed
NCT01034358 2012-10-23
Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease
Mayo Clinic
Phase 4 Completed
NCT00842738 2010-01-14
Can Alternative Treatment Have an Impact on Cervical Dysplasia?
University of Copenhagen
Phase 4 Unknown
NCT00733109 2010-01-11
CIN2
Universidade Cidade de Sao Paulo
Phase 4 Completed